{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:29:15Z","timestamp":1776785355494,"version":"3.51.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62303295"],"award-info":[{"award-number":["62303295"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62376150"],"award-info":[{"award-number":["62376150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62206165"],"award-info":[{"award-number":["62206165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272039, 82021002, and 8197164"],"award-info":[{"award-number":["82272039, 82021002, and 8197164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Innovation 2030 - Major Projects","award":["2022ZD021600"],"award-info":[{"award-number":["2022ZD021600"]}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2022M722034"],"award-info":[{"award-number":["2022M722034"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11440-4","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T13:34:22Z","timestamp":1740490462000},"page":"5525-5536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Annual percentage change of MR Parkinsonism index in progressive supranuclear palsy: a feasibility study"],"prefix":"10.1007","volume":"35","author":[{"given":"Min","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjie","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Rominger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuangyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuantao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4948-3683","authenticated-orcid":false,"given":"Jiehui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-Tao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Min","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Jie","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Zhao","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"11440_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41582-021-00541-5","volume":"17","author":"M Stamelou","year":"2021","unstructured":"Stamelou M, Respondek G, Giagkou N, Whitwell JL, Kovacs GG, H\u00f6glinger GU (2021) Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies. Nat Rev Neurol 17:601\u2013620. https:\/\/doi.org\/10.1038\/s41582-021-00541-5","journal-title":"Nat Rev Neurol"},{"key":"11440_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/s1474-4422(17)30157-6","volume":"16","author":"AL Boxer","year":"2017","unstructured":"Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, H\u00f6glinger GU (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16:552\u2013563. https:\/\/doi.org\/10.1016\/s1474-4422(17)30157-6","journal-title":"Lancet Neurol"},{"key":"11440_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00401-022-02479-4","volume":"144","author":"SF Roemer","year":"2022","unstructured":"Roemer SF, Grinberg LT, Crary JF et al (2022) Rainwater charitable foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy. Acta Neuropathol 144:603\u2013614. https:\/\/doi.org\/10.1007\/s00401-022-02479-4","journal-title":"Acta Neuropathol"},{"key":"11440_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/mds.29338","volume":"38","author":"FT Liu","year":"2023","unstructured":"Liu FT, Lu JY, Li XY et al (2023) 18) F-florzolotau positron emission tomography imaging of tau pathology in the living brains of patients with corticobasal syndrome. Mov Disord 38:579\u2013588. https:\/\/doi.org\/10.1002\/mds.29338","journal-title":"Mov Disord"},{"key":"11440_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"key":"11440_CR6","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s00415-022-11556-3","volume":"270","author":"J Jin","year":"2023","unstructured":"Jin J, Su D, Zhang J, Li X, Feng T (2023) Tau PET imaging in progressive supranuclear palsy: a systematic review and meta-analysis. J Neurol 270:2451\u20132467. https:\/\/doi.org\/10.1007\/s00415-022-11556-3","journal-title":"J Neurol"},{"key":"11440_CR7","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.28007","volume":"35","author":"S Nigro","year":"2020","unstructured":"Nigro S, Antonini A, Vaillancourt DE et al (2020) Automated MRI classification in progressive supranuclear palsy: a large international cohort study. Mov Disord 35:976\u2013983. https:\/\/doi.org\/10.1002\/mds.28007","journal-title":"Mov Disord"},{"key":"11440_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2020.01.019","volume":"72","author":"A Quattrone","year":"2020","unstructured":"Quattrone A, Morelli M, Quattrone A et al (2020) Magnetic resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: a longitudinal 2-year study. Parkinsonism Relat Disord 72:1\u20136. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.01.019","journal-title":"Parkinsonism Relat Disord"},{"key":"11440_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/mds.28364","volume":"36","author":"A Quattrone","year":"2021","unstructured":"Quattrone A, Antonini A, Vaillancourt DE et al (2021) A new MRI measure to early differentiate progressive supranuclear palsy from de novo Parkinson\u2019s disease in clinical practice: an international study. Mov Disord 36:681\u2013689. https:\/\/doi.org\/10.1002\/mds.28364","journal-title":"Mov Disord"},{"key":"11440_CR10","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/mds.28992","volume":"37","author":"A Quattrone","year":"2022","unstructured":"Quattrone A, Bianco MG, Antonini A et al (2022) Development and validation of automated magnetic resonance Parkinsonism index 2.0 to distinguish progressive supranuclear palsy-Parkinsonism from Parkinson\u2019s disease. Mov Disord 37:1272\u20131281. https:\/\/doi.org\/10.1002\/mds.28992","journal-title":"Mov Disord"},{"key":"11440_CR11","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1212\/wnl.0000000000003125","volume":"87","author":"A Quattrone","year":"2016","unstructured":"Quattrone A, Morelli M, Williams DR et al (2016) MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism. Neurology 87:1266\u20131273. https:\/\/doi.org\/10.1212\/wnl.0000000000003125","journal-title":"Neurology"},{"key":"11440_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12070949","author":"A Quattrone","year":"2022","unstructured":"Quattrone A, Morelli M, Bianco MG et al (2022) Magnetic resonance planimetry in the differential diagnosis between Parkinson\u2019s disease and progressive supranuclear palsy. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci12070949","journal-title":"Brain Sci."},{"key":"11440_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.parkreldis.2018.04.005","volume":"54","author":"C Mueller","year":"2018","unstructured":"Mueller C, Hussl A, Krismer F et al (2018) The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism. Parkinsonism Relat Disord 54:90\u201394. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.04.005","journal-title":"Parkinsonism Relat Disord"},{"key":"11440_CR14","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/mds.27038","volume":"32","author":"JL Whitwell","year":"2017","unstructured":"Whitwell JL, H\u00f6glinger GU, Antonini A et al (2017) Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? Mov Disord 32:955\u2013971. https:\/\/doi.org\/10.1002\/mds.27038","journal-title":"Mov Disord"},{"key":"11440_CR15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00702-017-1717-8","volume":"124","author":"B Heim","year":"2017","unstructured":"Heim B, Krismer F, De Marzi R, Seppi K (2017) Magnetic resonance imaging for the diagnosis of Parkinson\u2019s disease. J Neural Transm 124:915\u2013964. https:\/\/doi.org\/10.1007\/s00702-017-1717-8","journal-title":"J Neural Transm"},{"key":"11440_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1148\/radiol.2453061703","volume":"246","author":"A Quattrone","year":"2008","unstructured":"Quattrone A, Nicoletti G, Messina D et al (2008) MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 246:214\u2013221. https:\/\/doi.org\/10.1148\/radiol.2453061703","journal-title":"Radiology"},{"key":"11440_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jamaneurol.2019.4347","volume":"77","author":"E Jabbari","year":"2020","unstructured":"Jabbari E, Holland N, Chelban V et al (2020) Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome. JAMA Neurol 77:377\u2013387. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4347","journal-title":"JAMA Neurol"},{"key":"11440_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.07.016","volume":"54","author":"A Quattrone","year":"2018","unstructured":"Quattrone A, Morelli M, Nigro S et al (2018) A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson\u2019s disease. Parkinsonism Relat Disord 54:3\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.07.016","journal-title":"Parkinsonism Relat Disord"},{"key":"11440_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/mds.27621","volume":"34","author":"A Quattrone","year":"2019","unstructured":"Quattrone A, Morelli M, Vescio B et al (2019) Refining initial diagnosis of Parkinson\u2019s disease after follow-up: a 4-year prospective clinical and magnetic resonance imaging study. Mov Disord 34:487\u2013495. https:\/\/doi.org\/10.1002\/mds.27621","journal-title":"Mov Disord"},{"key":"11440_CR20","doi-asserted-by":"publisher","first-page":"2230196","DOI":"10.1155\/2021\/2230196","volume":"2021","author":"S Zhu","year":"2021","unstructured":"Zhu S, Ju Z, Wu P et al (2021) The Parkinson\u2019s disease progression neuroimaging initiative. Behav Neurol 2021:2230196. https:\/\/doi.org\/10.1155\/2021\/2230196","journal-title":"Behav Neurol"},{"key":"11440_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ane.13653","volume":"146","author":"QS Chen","year":"2022","unstructured":"Chen QS, Li XY, Li L et al (2022) Dopamine transporter imaging in progressive supranuclear palsy: severe but nonspecific to subtypes. Acta Neurol Scand 146:237\u2013245. https:\/\/doi.org\/10.1111\/ane.13653","journal-title":"Acta Neurol Scand"},{"key":"11440_CR22","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00259-022-06104-0","volume":"50","author":"FT Liu","year":"2023","unstructured":"Liu FT, Lu JY, Li XY et al (2023) (18)F-florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy. Eur J Nucl Med Mol Imaging 50:1395\u20131405. https:\/\/doi.org\/10.1007\/s00259-022-06104-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11440_CR23","doi-asserted-by":"publisher","unstructured":"Li L, Liu FT, Li M et al (2021) Clinical Utility of (18) F-APN-1607 Tau PET imaging in patients with progressive supranuclear palsy. Mov Disord. https:\/\/doi.org\/10.1002\/mds.28672","DOI":"10.1002\/mds.28672"},{"key":"11440_CR24","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/mds.29159","volume":"37","author":"FT Liu","year":"2022","unstructured":"Liu FT, Li XY, Lu JY et al (2022) (18) F-florzolotau tau positron emission tomography imaging in patients with multiple system atrophy-Parkinsonian subtype. Mov Disord 37:1915\u20131923. https:\/\/doi.org\/10.1002\/mds.29159","journal-title":"Mov Disord"},{"key":"11440_CR25","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1007\/s00259-022-05804-x","volume":"49","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Wu P, Wu J et al (2022) Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning. Eur J Nucl Med Mol Imaging 49:2798\u20132811. https:\/\/doi.org\/10.1007\/s00259-022-05804-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11440_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/jnnp-2019-321354","volume":"91","author":"M Picillo","year":"2020","unstructured":"Picillo M, Tepedino MF, Abate F et al (2020) Midbrain MRI assessments in progressive supranuclear palsy subtypes. J Neurol Neurosurg Psychiatry 91:98\u2013103. https:\/\/doi.org\/10.1136\/jnnp-2019-321354","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11440_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000121388","volume":"5","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 5:339\u2013346. https:\/\/doi.org\/10.1159\/000121388","journal-title":"Neurodegener Dis"},{"key":"11440_CR28","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","volume":"128","author":"DR Williams","year":"2005","unstructured":"Williams DR, de Silva R, Paviour DC et al (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u2019s syndrome and PSP-parkinsonism. Brain 128:1247\u20131258. https:\/\/doi.org\/10.1093\/brain\/awh488","journal-title":"Brain"},{"key":"11440_CR29","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mds.27408","volume":"33","author":"M Picillo","year":"2018","unstructured":"Picillo M, Erro R, Cuoco S et al (2018) MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes. Mov Disord 33:1361\u20131365. https:\/\/doi.org\/10.1002\/mds.27408","journal-title":"Mov Disord"},{"key":"11440_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2217\/nmt-2016-0027","volume":"6","author":"T Rittman","year":"2016","unstructured":"Rittman T, Coyle-Gilchrist IT, Rowe JB (2016) Managing cognition in progressive supranuclear palsy. Neurodegener Dis Manag 6:499\u2013508. https:\/\/doi.org\/10.2217\/nmt-2016-0027","journal-title":"Neurodegener Dis Manag"},{"key":"11440_CR31","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/mds.27964","volume":"35","author":"I Piot","year":"2020","unstructured":"Piot I, Schweyer K, Respondek G et al (2020) The progressive supranuclear palsy clinical deficits scale. Mov Disord 35:650\u2013661. https:\/\/doi.org\/10.1002\/mds.27964","journal-title":"Mov Disord"},{"key":"11440_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/mds.27546","volume":"34","author":"JL Whitwell","year":"2019","unstructured":"Whitwell JL, Tosakulwong N, Schwarz CG et al (2019) MRI outperforms [18F]AV-1451 PET as a longitudinal biomarker in progressive supranuclear palsy. Mov Disord 34:105\u2013113. https:\/\/doi.org\/10.1002\/mds.27546","journal-title":"Mov Disord"},{"key":"11440_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.irn.2018.08.010","volume":"142","author":"B Heim","year":"2018","unstructured":"Heim B, Krismer F, Seppi K (2018) Structural imaging in atypical Parkinsonism. Int Rev Neurobiol 142:67\u2013148. https:\/\/doi.org\/10.1016\/bs.irn.2018.08.010","journal-title":"Int Rev Neurobiol"},{"key":"11440_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/mds.23295","volume":"26","author":"EC Schofield","year":"2011","unstructured":"Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM (2011) Cortical atrophy differentiates Richardson\u2019s syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord 26:256\u2013263. https:\/\/doi.org\/10.1002\/mds.23295","journal-title":"Mov Disord"},{"key":"11440_CR35","doi-asserted-by":"publisher","first-page":"fcad048","DOI":"10.1093\/braincomms\/fcad048","volume":"5","author":"WJ Scotton","year":"2023","unstructured":"Scotton WJ, Shand C, Todd E et al (2023) Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning. Brain Commun 5:fcad048. https:\/\/doi.org\/10.1093\/braincomms\/fcad048","journal-title":"Brain Commun"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11440-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11440-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11440-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:09:21Z","timestamp":1755097761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11440-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["11440"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11440-4","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"26 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Jiehui Jiang.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}